Insider Shareholders with Direct Ownership of Mi Nk Therapeutics, Inc. (INKT)
This section provides a comprehensive overview of the insiders with direct ownership of Mi Nk Therapeutics, Inc. (INKT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
MiNK Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 1,946,494 | 10,440,231 | 21,772,863 $14.8 Million | 15 |
Oct 16, 2023
Added 0.0%
|
|
| 100,000 | 100,000 | 1,866,400 $1.27 Million | 2 |
May 05, 2023
Reduced 5.09%
|
|
| 127,222 | 0 | 405,296 $275,601 | 9 |
Sep 03, 2024
Added 5.1%
|
|
|
Jennifer Buell
Chief Executive Officer |
867,740 | 844,300 | 232,165 $157,872 | 6 |
Oct 11, 2023
Reduced 74.98%
|
| 126,331 | 0 | 126,107 $85,752 | 9 |
Sep 03, 2024
Added 14.65%
|
|
| 123,882 | 0 | 123,705 $84,119 | 11 |
Sep 03, 2024
Added 12.88%
|
|
| 109,428 | 0 | 109,234 $74,279 | 9 |
Sep 03, 2024
Added 14.65%
|
|
| 41,374 | 0 | 41,193 $28,011 | 5 |
Sep 01, 2023
Added 19.29%
|
|
|
Marcus Antonius Van Dijk
Chief Scientific Officer |
51,628 | 24,265 | 27,363 $18,606 | 2 |
Jan 09, 2023
Reduced 47.0%
|